Neurocrine Biosciences (NBIX) said late Tuesday it named Andrew Ratz as chief technical operations officer.
He was most recently the senior vice president of drug development, delivery, and device at the company, according to a statement.
Neurocrine Biosciences (NBIX) said late Tuesday it named Andrew Ratz as chief technical operations officer.
He was most recently the senior vice president of drug development, delivery, and device at the company, according to a statement.
Comments